Kamada Ltd. (KMDA) Financial Ratios
18 years of historical data (2008–2025) · Healthcare · Drug Manufacturers - Specialty & Generic
EV/EBITDA
↓
9.26
↓-54% vs avg
5yr avg: 20.08
30Y Low7.8·High67.7
P/FCF
↑
28.14
↑+105% vs avg
5yr avg: 13.71
30Y Low7.2·High26.5
P/B Ratio
↓
1.79
↑+29% vs avg
5yr avg: 1.38
30Y Low1.0·High5.5
ROE
↑
8.3%
↓+169% vs avg
5yr avg: 3.1%
30Y Low-103%·High22%
Debt/EBITDA
↓
0.26
↓-82% vs avg
5yr avg: 1.44
30Y Low0.1·High41.7
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
KMDA Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Kamada Ltd. trades at 22.3x earnings, 20% below its 5-year average of 28.1x, sitting at the 57th percentile of its historical range. This is roughly in line with the Healthcare sector median P/E of 22.3x. On a free-cash-flow basis, the stock trades at 28.1x P/FCF, 105% above the 5-year average of 13.7x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $476M | $412M | $352M | $328M | $180M | $295M | $289M | $277M | $203M | $181M | $199M |
| Enterprise Value | $413M | $348M | $285M | $282M | $166M | $300M | $224M | $240M | $186M | $170M | $190M |
| P/E Ratio → | 22.32 | 19.08 | 24.36 | 40.80 | — | — | 15.80 | 11.98 | 9.09 | 26.39 | — |
| P/S Ratio | 2.44 | 2.11 | 2.19 | 2.30 | 1.39 | 2.84 | 2.17 | 2.18 | 1.77 | 1.76 | 2.56 |
| P/B Ratio | 1.79 | 1.53 | 1.36 | 1.35 | 1.02 | 1.67 | 1.62 | 2.05 | 1.80 | 2.02 | 2.97 |
| P/FCF | 28.14 | 24.32 | 9.55 | — | 7.25 | — | 21.22 | 10.63 | 26.45 | — | — |
| P/OCF | 17.27 | 14.93 | 7.40 | 76.13 | 6.29 | — | 15.12 | 9.75 | 19.22 | 46.46 | 104.65 |
P/E links to full P/E history page with 30-year chart
KMDA EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Kamada Ltd.'s enterprise value stands at 9.3x EBITDA, 54% below its 5-year average of 20.1x. The Healthcare sector median is 14.4x, placing the stock at a 36% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.78 | 1.77 | 1.98 | 1.28 | 2.90 | 1.68 | 1.89 | 1.62 | 1.65 | 2.46 |
| EV / EBITDA | 9.26 | 7.81 | 8.41 | 13.08 | 9.95 | 61.14 | 9.14 | 8.80 | 8.14 | 15.32 | — |
| EV / EBIT | 14.53 | 12.25 | 20.35 | 27.99 | — | — | 11.09 | 10.32 | 9.34 | 22.38 | — |
| EV / FCF | — | 20.55 | 7.73 | — | 6.70 | — | 16.43 | 9.22 | 24.26 | — | — |
KMDA Profitability
Margins and return-on-capital ratios measuring operating efficiency
Kamada Ltd. earns an operating margin of 14.5%. Operating margins have expanded from 7.1% to 14.5% over the past 3 years, signaling improving operational efficiency. ROE of 8.3% is modest. ROIC of 10.7% represents solid returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 40.1% | 40.1% | 43.5% | 38.9% | 36.1% | 29.3% | 35.7% | 39.1% | 36.2% | 31.2% | 27.9% |
| Operating Margin | 14.5% | 14.5% | 12.5% | 7.1% | 3.5% | -0.7% | 14.4% | 17.9% | 16.8% | 7.2% | -7.5% |
| Net Profit Margin | 11.2% | 11.2% | 9.0% | 5.8% | -1.8% | -2.2% | 12.9% | 17.5% | 19.5% | 6.7% | -8.7% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 8.3% | 8.3% | 5.7% | 3.9% | -1.3% | -1.3% | 10.9% | 18.0% | 22.1% | 8.8% | -9.7% |
| ROA | 5.8% | 5.8% | 4.0% | 2.4% | -0.7% | -0.8% | 8.9% | 14.3% | 17.1% | 6.2% | -6.7% |
| ROIC | 10.7% | 10.7% | 7.7% | 4.2% | 2.0% | -0.4% | 13.6% | 17.6% | 16.6% | 8.1% | -6.9% |
| ROCE | 8.7% | 8.7% | 6.4% | 3.6% | 1.8% | -0.3% | 11.8% | 17.8% | 18.6% | 9.0% | -7.7% |
KMDA Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Kamada Ltd. carries a Debt/EBITDA ratio of 0.3x, which is very conservative (92% below the sector average of 3.3x). The company holds a net cash position — cash of $75M exceeds total debt of $12M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns. Interest coverage of 30.4x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.04 | 0.04 | 0.04 | 0.04 | 0.12 | 0.14 | 0.03 | 0.04 | 0.01 | 0.02 | 0.03 |
| Debt / EBITDA | 0.26 | 0.26 | 0.33 | 0.41 | 1.23 | 4.96 | 0.20 | 0.21 | 0.06 | 0.18 | — |
| Net Debt / Equity | — | -0.24 | -0.26 | -0.19 | -0.08 | 0.03 | -0.37 | -0.27 | -0.15 | -0.12 | -0.12 |
| Net Debt / EBITDA | -1.44 | -1.44 | -1.99 | -2.17 | -0.82 | 1.17 | -2.67 | -1.35 | -0.74 | -0.96 | — |
| Debt / FCF | — | -3.77 | -1.83 | — | -0.55 | — | -4.79 | -1.42 | -2.19 | — | — |
| Interest Coverage | 30.36 | 30.36 | 30.38 | 7.75 | 4.96 | -2.46 | 72.32 | 77.76 | 58.87 | 90.78 | -46.36 |
Net cash position: cash ($75M) exceeds total debt ($12M)
KMDA Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Kamada Ltd.'s current ratio of 4.07x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 2.28x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has improved from 3.43x to 4.07x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.07 | 4.07 | 3.73 | 3.43 | 1.84 | 2.41 | 7.13 | 4.39 | 4.70 | 3.30 | 2.83 |
| Quick Ratio | 2.28 | 2.28 | 2.14 | 1.64 | 0.88 | 1.08 | 5.40 | 3.07 | 3.46 | 2.58 | 1.89 |
| Cash Ratio | 1.59 | 1.59 | 1.59 | 1.12 | 0.45 | 0.34 | 4.38 | 2.26 | 2.15 | 1.46 | 1.05 |
| Asset Turnover | — | 0.52 | 0.43 | 0.40 | 0.40 | 0.33 | 0.63 | 0.73 | 0.83 | 0.84 | 0.78 |
| Inventory Turnover | 1.38 | 1.38 | 1.15 | 0.98 | 1.14 | 1.02 | 1.99 | 1.79 | 2.49 | 3.36 | 2.18 |
| Days Sales Outstanding | — | 54.27 | 52.60 | 54.52 | 80.02 | 125.24 | 63.15 | 72.40 | 94.06 | 113.49 | 102.65 |
KMDA Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Kamada Ltd. returns 2.6% to shareholders annually primarily through dividends. A payout ratio of 57.1% is moderate and appears sustainable, balancing shareholder returns with reinvestment capacity. The earnings yield of 4.5% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 2.6% | 3.0% | — | — | — | — | — | — | — | — | — |
| Payout Ratio | 57.1% | 57.1% | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 4.5% | 5.2% | 4.1% | 2.5% | — | — | 6.3% | 8.3% | 11.0% | 3.8% | — |
| FCF Yield | 3.6% | 4.1% | 10.5% | — | 13.8% | — | 4.7% | 9.4% | 3.8% | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 2.6% | 3.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $58M | $58M | $54M | $45M | $45M | $45M | $41M | $41M | $38M | $36M |
Peer Comparison
Compare KMDA with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 KMDAYou | $476M | 22.3 | 9.3 | 28.1 | 40.1% | 14.5% | 8.3% | 10.7% | 0.3 |
 ADMA | $2B | 14.1 | 10.1 | 73.1 | 57.4% | 37.5% | 35.6% | 36.0% | 0.4 |
 GRFS | $7B | 12.1 | 8.5 | 7.7 | 35.7% | 16.4% | 4.8% | 5.4% | 5.4 |
 BIO | $7B | 9.2 | 16.7 | 18.5 | 52.0% | 10.5% | 10.8% | 2.6% | 3.2 |
 BHVN | $1B | -1.4 | — | — | — | — | -310.8% | -242.1% | — |
 RARE | $3B | -4.5 | — | — | 83.8% | -79.5% | -607.5% | -89.4% | — |
 PRTA | $567M | -2.3 | — | — | 61.8% | -1905.8% | -63.6% | -2099.8% | — |
 ACAD | $4B | 9.9 | 26.9 | 36.7 | 91.7% | 9.8% | 39.9% | 10.0% | 0.4 |
 FOLD | $5B | -164.8 | 114.9 | 152.4 | 87.3% | 5.4% | -11.6% | 5.3% | 11.5 |
 CSL | $15B | 21.1 | 13.8 | 15.2 | 35.7% | 19.9% | 34.8% | 20.6% | 2.4 |
 BAX | $9B | -10.0 | 25.4 | 28.0 | 30.1% | -2.7% | -14.6% | -1.4% | 14.9 |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 18 years · Updated daily
See KMDA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs KMDA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare KMDA vs ADMA
Side-by-side business, growth, and profitability comparison vs ADMA Biologics, Inc..
Start ComparisonKMDA — Frequently Asked Questions
Quick answers to the most common questions about buying KMDA stock.
What is Kamada Ltd.'s P/E ratio?
Kamada Ltd.'s current P/E ratio is 22.3x. The historical average is 21.1x. This places it at the 57th percentile of its historical range.
What is Kamada Ltd.'s EV/EBITDA?
Kamada Ltd.'s current EV/EBITDA is 9.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 20.9x.
What is Kamada Ltd.'s ROE?
Kamada Ltd.'s return on equity (ROE) is 8.3%. The historical average is -12.9%.
Is KMDA stock overvalued?
Based on historical data, Kamada Ltd. is trading at a P/E of 22.3x. This is at the 57th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What is Kamada Ltd.'s dividend yield?
Kamada Ltd.'s current dividend yield is 2.59% with a payout ratio of 57.1%.
What are Kamada Ltd.'s profit margins?
Kamada Ltd. has 40.1% gross margin and 14.5% operating margin. Operating margin between 10-20% is typical for established companies.
How much debt does Kamada Ltd. have?
Kamada Ltd.'s Debt/EBITDA ratio is 0.3x, indicating low leverage. A ratio below 2x is generally considered financially healthy.